Vertex Pharmaceuticals · 10 hours ago
Access Strategy Analytics & Insights Director
Boston, MA
Full-time
Hybrid
Director/Executive
$201K/yr - $302K/yr
10+ years expVertex Pharmaceuticals is seeking a dynamic leader as the Director of Data and Analytics Capabilities to join our U.S. Market Access organization leading transformative innovation within the Data & Analytics Center of Excellence. This role involves shaping and leading AI-powered decision-making across Market Access functions and managing a team of data analysts and scientists to drive business results and transform patient outcomes.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Responsible for developing and executing a data & analytics capabilities that enables scalable insights across in line brands, pipeline assets aligning with US Market Access business priorities to drive business results and transform patient outcomes
Manage direct reports that have Data Enablement, Data Governance and Advanced Analytics responsibilities
Oversee the Data Enablement, to lead the establishment a common data foundation of analytics ready data products, ensuring seamless data and analytics capability integration across multiple data domains including payer accounts and field operations, pricing, chargebacks and reimbursements, trade and distribution and 3rd party data acquisition and vendor management
Oversee the Data Governance, to lead the implementation of a data governance framework, driving data discipline, integrity, security, and compliance to strengthen the baseline for D&A innovation
Take charge of the Advanced Analytics capabilities, building a strong team over time, to enable real-time insights through AI-driven models, self-service analytics, and predictive intelligence to generate pipeline value narratives for market shaping, strengthen coverage and utilization via access expansion and barrier reduction, and drive launch success
Elevate analytics with Advanced ML, implementing multi-level analytical models to accurately attribute 340B vs. non-340B dispenses, stop 340B revenue leakage, using isolation forests for anomaly detection
Drive new KPIs and continuous performance monitoring in post-deal analytics, identifying opportunities for pull-through effectiveness and provide inputs to inform pre-deal feasibility assessment
Foster a data-driven culture by leading enterprise-wide data literacy and training initiatives, empowering Payer Field teams, Trade & Distribution, Pricing & Contracting teams to leverage AI/ML-powered insights
Lead change management efforts to embed Gen AI-enhanced data & analytics capabilities into strategic decision-making, ensuring agility and scalability including intelligent knowledge hub with conversational agent interfaces
Partner with Digital Technology & Engineering (DTE), GIACO (Global Insights Analytics & Commercial Operations), HEOR, DSS (Data Strategy & Solutions) to create a seamless AI-powered data ecosystem
Monitor emerging technologies, trends, and best practices, ensuring continuous innovation in ML, Generative AI, and analytics-driven decision-making
Partner with DTE (Digital Technology & Engineering), GIACO (Global Insights Analytics and Commercial Operations) members to describe the current state of the business and identify the factors influencing them (the “Why” behind the “What”)
Serve as an advocate and develop strong partnerships in integrating market access insights across the Vertex enterprise
Qualification
Required
Master's degree in a quantitative discipline required (e.g., Engineering, Statistics, Economics, Finance) required
10+ years of experience in the biotech/pharmaceuticals industries in Managed Markets or in biopharma consulting (analytics, management, or strategic) post-MBA/PhD, with meaningful biotech/pharmaceuticals and quantitative decision support experience
7+ years of experience in developing insights that inform value, access, reimbursement, and contracting strategies
Proficiency in D&A with deep expertise in evolving U.S. Market Access strategies, payer account management, channel dynamics, payer/distribution channels (commercial, government, SP, GPOs, etc.)
Demonstrated experience working with syndicated Market Access databases (IQVIA, MMIT etc.) and shipment data (852, 867, Integrichain, etc.)
Strong analytical capabilities with expertise in data analysis tools (e.g., Excel, SQL, SAS, Alteryx, PowerBI), with a working knowledge of analytical tools/software such as R, Python and data warehouse platforms (Snowflake)
Ability to network with internal and external stakeholders capable of forming strong, productive partnerships
Strategic thinker who can see operational trends, identify necessary activities, and summarize their impact to the bigger strategic picture
Strong written and verbal communication skills, strong presentation skills to C-suite management and external stakeholders
Flexible, adaptable, diplomatic, and able to effectively deal with ambiguity
Ability to partner and communicate with senior leadership to support financial forecasting and analytics, and/or commercial launch planning
Strong story telling skills with the ability to distill complex information synthesized into concise, impactful messages
Preferred
PhD or MBA/ MPH in combination with a Master's in a quantitative discipline
Good understanding of state/federal policies, government programs impacting market access, and statutory government pricing methodologies
8-10 years of pharmaceutical manufacturer market access experience and subject matter expertise with Health Plans, PBMs, Hospital Systems, Specialty Pharmacies and Healthcare Policy stakeholders
Diverse US product launch experience across different therapeutic areas strongly preferred
Benefits
Annual bonus
Annual equity awards
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
5001-10000 employees
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Reshma Kewalramani
CEO and President
Nina Devlin
Senior Vice President, Chief Communications Officer
Recent News
2026-01-13
2026-01-12
Company data provided by crunchbase